Assessment of Full Blood Count Parameters in Patients with End Stage Renal Disease (ESRD) on Regular Haemodialysis

Main Article Content

Tharindu Alagiyawanna
Sajani Ranawaka
Piumanthi Karunarathne
Chandima Kulathilake


Background: Haematological profile is commonly affected in chronic kidney disease and this becomes more apparent as the disease progresses. The aim of this study was to assess full blood count (FBC) parameters in a cohort of Sri Lankan patients with End Stage Renal disease (ESRD) on regular haemodialysis.

Materials and Methods: This comparative cross-sectional study included hundred (100) patients with ESRD on regular haemodialysis, who were recruited from haemodialysis units of Colombo South Teaching Hospital (CSTH) and National Institute of Nephrology Dialysis Transplantation (NINDT) in Sri Lanka. Full blood count and serum ferritin were done in all the patients. Data were analysed statistically by using SPSS (version 19.0) data base.

Results: The cohort of hundred individuals included 60% male and 40% female patients. In this cohort, majority (n=83, 83%) were either severely or moderately anaemic with a haemoglobin less than 10.9g/dL(WHO cut off) despite erythropoietin treatment. Majority had a normal mean corpuscular volume (MCV) (n=63, 63%), but 96 (96%) patients had an increased red cell distribution width-coefficient variation (RDW-CV) indicating anisocytosis. Ninety (90%) patients had a normal total white cell count and ninety nine (99%) patients had a normal absolute reticulocyte count. Thrombocytopenia was noted in 29(29%) patients. There was no statistically significant correlation between serum ferritin and the two indices MCV and MCH

Conclusion: In our cohort, patients showed varying abnormalities in haematological parameters which were comparable to previous studies. Most importantly, anaemia and thrombocytopenia are anticipated in these patients, so that regular monitoring of haemoglobin and platelet count is indicated in chronic renal failure patients undergoing haemodialysis.

Chronic kidney disease, end stage renal disease, haemodialysis, anaemia, thrombocytopenia

Article Details

How to Cite
Alagiyawanna, T., Ranawaka, S., Karunarathne, P., & Kulathilake, C. (2020). Assessment of Full Blood Count Parameters in Patients with End Stage Renal Disease (ESRD) on Regular Haemodialysis. Asian Journal of Research in Nephrology, 3(2), 26-32. Retrieved from
Original Research Article


Poothullil J, Shimizu A, Day R, Dolovich J. Anaphylaxis from the product (s) of ethylene oxide gas. Annals of Internal Medicine. 1975;82(1):58-60.

Asaduzzaman M, Shobnam A, Farukuzzaman M, Gaffar A, Juliana FM, Sharker T, et al. Assessment of red blood cell indices, white blood cells, platelet indices and procalcitonin of chronic kidney disease patients under hemodialysis; 2018.

Chowdhury MNU, Khatun M, Dutta PK, Akhter N. Effects of haemodialysis on red cell indices and haematocrit in chronic kidney disease patients. Chattagram Maa-O-Shishu Hospital Medical College Journal. 2017;16(1):15-8.

Buemi M, Floccari F, Di Pasquale G, Cutroneo G, Sturiale A, Aloisi C, et al. AQP1 in red blood cells of uremic patients during hemodialytic treatment. Nephron. 2002;92(4):846-52.

Vanholder R, Vanbelleghem H, Lameire N, Eknoyan G. Response to ‘hemoglobin level in dialysis patients: Revisiting the normal hematocrit study’. Kidney International. 2007;72(9):1161-2.

Habib A, Ahmad R, Rehman S. Hematological changes in patients of chronic renal failure and the effect of hemodialysis on these parameters. Int J Res Med Sci. 2017;5:4998-5003.

Levin A, Bakris G, Molitch M, Smulders M, Tian J, Williams L, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney International. 2007;71(1):31-8.

Locatelli F, Pozzoni P, Del Vecchio L. Recombinant human epoetin beta in the treatment of renal anemia. Therapeutics and Clinical Risk Management. 2007;3(3): 433.

Vos FE, Schollum JB, Coulter CV, Doyle TC, Duffull SB, Walker RJ. Red blood cell survival in long-term dialysis patients. American Journal of Kidney Diseases. 2011;58(4):591-8.

Ratcliffe PJ. Molecular biology of erythropoietin. Kidney International. 1993; 44(4):887-904.

Eschbach Jr J, Funk D, Adamson J, Kuhn I, Scribner B, Finch C. Erythropoiesis in patients with renal failure undergoing chronic dialysis. New England Journal of Medicine. 1967;276(12):653-8.

Karnad A, Poskitt TR. The automated complete blood cell count: Use of the red blood cell volume distribution width and mean platelet volume in evaluating anemia and thrombocytopenia. Archives of Internal Medicine. 1985;145(7):1270-2.

Evans TC, Jehle D. The red blood cell distribution width. The Journal of Emergency Medicine. 1991;9:71-4.

Akinsola A, Durosinmi M, Akinola N. The haematological profile of Nigerians with chronic renal failure. African Journal of Medicine and Medical Sciences. 2000; 29(1):13-6.

Oluboyede O, Williams A. Serum ferritin and other iron indices in adult Nigerians with chronic renal failure--review of management of anaemia. African Journal of Medicine and Medical Sciences. 1995; 24(3):231-7.

Katz I. Kidney and kidney related chronic diseases in South Africa and chronic disease intervention program experiences. Advances in Chronic Kidney Disease. 2005;12(1):14-21.

Gafter U, Bessler H, Malachi T, Zevin D, Djaldetti M, Levi J. Platelet count and thrombopoietic activity in patients with chronic renal failure. Nephron. 1987;45(3): 207-10.

Dorgalaleh A, Mahmudi M, Tabibian S, Khatib ZK, Tamaddon GH, Moghaddam ES, et al. Anemia and thrombocytopenia in acute and chronic renal failure. International Journal of Hematology-Oncology and Stem Cell Research. 2013; 7(4):34.

Hakim YA, Abbas A, Khalil A, Mustafa THIA. The effect of hemodialysis on hemoglobin concentration, platelets count and white blood cells count in end stage renal failure. International Journal of Medical Research & Health Sciences. 2016;5(5):22-35.

Chakravarti A, Ukey A, Bajaj P, Saragade P. A Study of hematological profile in patients of chronic renal failure undergoing hemodialysis at a tertiary health care institute. MVP Journal of Medical Sciences. 2017;4(2): 107-12.